| 标题 |
A phase 3, randomized, double-blind, active-controlled clinical study to compare BAT2206, a ustekinumab biosimilar, with ustekinumab reference product in patients with moderate-to-severe psoriasis: Treatment period 2 results (post Week 28 to Week 52) |
| 备注 |
如有补充材料,“正文+补充材料”一起下载
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of The American Academy of Dermatology 作者:Xiao‐Yong Man; Katya Zaharieva; Grażyna Pulka; Agnieszka Żebrowska; Yunhua Deng; et al 出版日期:2025-08-09 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)